Allelic variants of genes: Angiotensin I-converting enzyme (ACE), angiotensin-II type 1 receptor (AT1R), methylenetetrahydrofolate reductase and left ventricular mass in patients with myocardial infarction;Warianty alleliczne genów enzymu konwertuja̧cego angiotensynȩ I (ACE), receptora angiotensyny II typu 1 (AT1R) oraz reduktazy metylenotetrahydrofolianowej (MTHFR) a masa lewej komory serca u chorych po przebytym zawale miȩśnia sercowego

Polskie Archiwum Medycyny Wewnetrznej

Volumn 115, Issue 2, 2006, Pages 105-111

  Gora̧cy, Jarosław ^b,c   Peregud Pogorzelska, Małgorzata ^b   Gora̧cy, Iwona ^a   Kaczmarczyk, Mariusz ^a   Kornacewicz Jach, Zdzisława ^b   Naruszewicz, Marek ^a   Ciechanowicz, Andrzej ^a  

^a Katedra Diagnostyki Laboratoryjnej   (Poland)

^b Klinika Kardiologii PAM   (Poland)

^c POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

Angiotensin 1 converting enzyme; Angiotensin II type 1 receptor; Gene polymorphism; Myocardial infarction

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ANGIOTENSIN 2 RECEPTOR; DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; ENZYME LOCALIZATION; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HEART INFARCTION; HEART LEFT VENTRICLE MASS; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

EID: 33745906970     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Tiret L., Bonnardeux A., Poirier O. Synergistic effects of angiotensin-converting enzyme and angiotensin-II type I receptor gene polymorphism on risk of myocardial infarction. Lancet. 1994; 344: 910.
2. Nakauchi Y., Suehiro T., Yamamoto M. Significance of angiotensin I-converting enzyme and angiotensin II type 1 receptor gene polymorphisms as risk factors for coronary heart disease. Atherosclerosis. 1996; 125: 161.
3. Evans R.W.-, Shaten B.J., Hempel J.D., Cutler J.A., Kuller L.H. Homocysteine and risk cardiovascular disease in the multiple risk factor intervention trial. Arterioscler Thromb Vasc Biol. 1997; 17: 1947.
4. Ma J., Stampfer M.J., Hennekens C.H. i wsp. Metylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine and risk of myocardial infarction in US physicians. Circulation 1996; 94: 2410.
5. Devereux R.B., Lutas E.M., Casale P.N. i wsp. Standardization of M-mode echocardiografic left ventricular anatomic measurements. J Am Coll Cardiol. 1984; 4: 1222.
6. Lindpaintner K., Pfeffer M.A., Kreutz R. i wsp. A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischaemic heart disease. N Eng J Med. 1995; 11: 706.
7. Nakauchi Y., Suehiro T., Yamamoto M. Significance of angiotensin I-converting enzyme and angiotensin II type 1 receptor gene polymorphisms as risk factors for coronary heart disease. Atherosclerosis 1996; 125: 161.
8. Frosst P., Blom H.J., Milos R. i wsp. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet. 1995; 10: 111.
9. Fatini C., Abbate R., Pepe G. i wsp. Searching for a better assessment of the individual coronary risk profile. The role of angiotensin-converting enzyme, angiotensin II type 1 receptor and angiotensinogen gene polymorphisms. Eur Heart J. 2000; 21: 633.
10. Jenuemaitre X., Ledru F., Battaglia S. i wsp. Genetic polymorphisms of the renin-angiotensin system and angiographic extent and severity of coronary artery disease: the Corgene study. Sum Genet. 1997; 99: 66.
11. Canavy I., Henry M., Tiret L. i wsp. Genetic polymorphisms and coronary artery disease in the South of France. Thromb Haemost. 2000; 83: 212.
12. Evans A.E., Poirier O., Kee F. Polymorphism of the angiotensin- converting-enzyme gene in subjects who died from coronary heart disease. QJM. 1994; 87: 211.
13. Costerousse O., Allegrini J., Lopez M., Alhenc-Galeas F. Angiotensin I converting enzyme in human circulatory mononuclear cells: genetic polymorphism of expression in T lymphocytes. Biochem J. 1993; 290: 33.
14. Tiret L., Rigat B., Visvikis S. i wsp. Evidence, from combined segreagtion and linkage analysis, that a variant of the angiotensin I-converting (ACE) gene controls plasma ACE levels. Am J Hum Genet. 1992; 51: 197.
15. Combien G., Paoletti E., Barocci S. i wsp. Plasma level and gene polymorphism of angiotensin converting enzyme in relation to myocardial infarction. Circulation 1994; 90: 669.
16. Combien F., Costerousse O., Tiret L. i wsp. Plasma level and gene polymorphism of angiotensin converting enzyme in relation to myocardial infarction. Circulation. 1994; 90: 669.
17. Ravera M., Viazzi F., Berruti V. i wsp. 5,10 metylenetetrahydrofolate reductase polymorfism and early organ damage in primary hypertension. AJH. 2001; 14: 371.
18. Galinsky D., Tysoe C., Brayne C.E. i wsp. Analysis of the apo E/apo C-1, angiotensin converting enzyme and metylenetetrahydrofolate reductase genes as candidates affecting human longevity. Atherosclerosis. 1997; 129: 177.
19. Simone G., Wachtello K., Palmieri V. i wsp. Body build and risk of cardiovascular events in hypertension and left ventricular hypertrophy. The LIVE study. Circulation. 2005; 111: 1924.
20. Fyhrquist F., Dahlof B., Devereux R.B. i wsp. Puls pressure and effects of losartan or atenolol in patiens with hypertension and left ventricular hypertrophy, Hypertension. 2005; 45: 580.
21. Schunkert H., Hense H.W., Holmer S.R. i wsp. Association between a deletion polymorphism of the angiotensin-converting enzyme gene and left ventricular hypertrophy. N Engl J Med. 1994; 330: 1634.
22. Osterop APRM, Kofflard MJM, Sandkuijl L.A. i wsp. AT1 receptor A/C 1166 polymorphism contributes to cardiac hypertrophy in subjects with hypertrophic cardiomyopathy. Hypertension. 1998; 32: 825.
23. Karaali Z.E., Agachan B., Yilmaz H., Isbir T. Angiotensin converting enzyme I/D gene polymorphisms and effects of left ventricular hypertrophy in Turkish myocardial infarction patients. Acta Cardiol. 2004; 59: 493.
24. Ylmaz H., Agachan B., Ergen A. i wsp. Methylenetetrahydrofolate reductase C677T mutation and left ventricular hypertrophy in turkish patients with type II diabetes mellitus, J Bioch And Molec Biol 2004; 37: 234.
25. Canella G., Paoletti E., Barocci S. i wsp. Angiotensin converting enzyme gene polymorphism and reversibility of uremic left ventricular hypertrophy following long term antihypertensive therapy. Kidney Int. 1998; 54: 618.